Skip to main content
Caplight Logo









Newton Biocapital

Newton Biocapital

Brusselsnewtonbiocapital.com

Overview

Newton Biocapital is a venture capital firm that invests in early-stage biotech and life science companies in Europe and Japan, with a focus on finding solutions for chronic diseases.

Year Founded

2017

Portfolio Companies

10

Investments

Newton Biocapital investments
CompanyDateStageLead
BioxodesDec 2025Series BLead
EPICS TherapeuticsSep 2025VC RoundLead
Augustine TherapeuticsMar 2025Series ACo-investor
Tensegrity Pharma, Inc.Nov 2024SeedLead
EPICS TherapeuticsOct 2024Series A ExtensionLead
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBrussels
Year Founded2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?